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Porphyria cutanea tarda (PCT)-like photosensitivity 
eruptions have occurred in patients treated with nali-
dixic acid, furosemide (Lasix), or tetracycline. An ani-
mal model for nalidixic acid photosensitivity was devel-
oped in young CF -1 female mice. The hair on the back 
was plucked from groups of animals that were injected 
i.p. each day with nalidixic acid or saline. The animals 
were exposed to black-lamp radiation for 12 h daily for 
6 weeks, followed by a 2-week rest period, and then 4 
more weeks of UV radiation exposure. The nalidixic 
acid-treated animals developed far greater gross and 
chronic inflammatory changes than the saline-treated 
animals; microscopically and ultrastructurally they 
showed blister formation beneath the basal lamina at 
the same level as that found in PCT. This model appears 
to be suitable for the study of PCT-like and other pho-
tosensitivity reactions. 
In recent yea rs a porphyria cutanea tarda (PCT)-like disease 
has been reported in patients who had no biochemical evidence 
of porphyria. The suspected etio logies in these cases have been 
diverse; renal failure, dia lysis and a number of pharmacologic 
age nts have been implicated. The first of several reports of 
phototoxic bu ll ous eruptions associated with nalidixic acid 
therapy appeared in 1964 [1] . Photoreactions, apparently to 
t his drug, were PCT -like clinically, and skin fragility was noted 
in some cases; hi stopathologically they showed subepidermal 
noninflammatory blisters (2- 4]. Many of the reported patients 
were not in renal fai lure and none was on hemodialysis. In 
some cases t he persistence of photosensitivity for severa l 
months foll owing drug withdrawal was noted [4,5]. Biochemical 
evidence for porphyria was not found in any of the nalidixic 
acid -assoc iated cases. Similarly, tetracycline was implicated in 
PCT-like photosensitive eruptions in patients not in renal 
failure o r on dia lysis (6] . Furosemide has a lso been associated 
with PCT-like photosensitive eruptions, but some of these 
patients have presented more complex diagnostic cons idera-
tions in that they were in chronic renal failure or on hemodi-
a lysis [7- 9]. It is apparent, nonetheless, that nalidixic acid, 
furose mide, and tetracycline may induce PCT-Iike photosen-
s it ive eruptions in patients in whom PCT is absent. 
We have developed a model for the experimental study of 
drug-induced PCT -like photosensitivity using nalidixic acid as 
the photosens itizing agent and CF -1 mice as the experimenta l 
a nimal. In these mice, phototoxic eruptions were observed that 
histologically and ultrastructurally were s imilar to the chan ges 
see n in P CT-like eruptions and in PCT. 
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Our projected initial use for the model was to attempt to 
identify the substrate on which the primary photoreaction acts 
and to determine how that reaction produces the PCT-lik~ 
changes in the skin. 
MATERIALS AND METHODS 
Carsworth Farms f/ 1 female mice, weighing 20- 25 g (Charles River 
Portage, Michigan) were used in th is study. Each animal cage usecl 
measured 42 em long, 24 em wide, and 14 em deep. The top was 
outfitted with a fixture (U ltrav iolet Products Corp., San Gabriel, Cal-
iforn ia) holding two 15-W f1uorescent black-light bulbs (Sylvania F-15 
T8-Blb). The irradiance of the two bulbs was determined for wave-
lengths ranging from 250- 400 nm , with an Optronics Spectra-radiome-
ter, Model ff742B (Fig 1) (Optronics Laboratory, Orlando, Florida) 
using cosine correcting diffusers. The distance from the lower edge of 
the lamp fixture to the detector was 17.5 em. No UV energy of 
wavelengths less than 300 nm was detected. No attempt was made to 
shield the an imals from the UVB portion of the lamp's output, except 
during the pilot experiment noted in Discussion. Bulbs were regularly 
replaced afte r 1 month of use. 
A nalidixic acid suspension was prepared fresh weekly by mixing 
nalidixic acid powder (Winthrop Laboratories, New York, New York) 
with normal saline and adjusting the pH to 7.4. The nalidixic acid 
suspension was stored in an opaque via l at 4"C. The absorption spec-
trum of nalidi xic acid shows peaks at approximately 250 and 325 nm 
[4]. 
Hairs on the backs of t he mice were plucked at the outset and then 
shaved every 2- 3 weeks thereafter as necessary. 
The final protocol outlined below was based on the results of exten-
sive preliminary experiments. Groups of 5- 10 plucked animals had 
been injected with nalidixic ac id or physiologic saline and exposed to 
constant or intermittent UV energy for varying periods of time. Careful 
observations of t he gross and microscopic responses of t hese groups of 
animals were assessed at multiple intervals throughout the experimen-
tal periods. Numerous spot qualitative urine porphyrin examinations 
were also made. In all the UV -treated animals receiving nalidixic acid 
marked inflammatory changes, noted within the first week, continued 
throughout the experimental period except when a rest period was 
included at the end of a 3- to 6-week irradiation period. When a 2-
week rest period was incorporated, followed by another irradiation 
period, inf1ammatory changes largely resolved and then recurred but 
were less severe, a llowi ng much more accurate evaluation of the path-
ologic changes found at the dermal-epidermal junction. Therefore, only 
the results of the final protocol were subjected to detailed light and 
electro n microscopic analys is. All ofthe pathologic alterations reported 
below were also observed in the preliminary experimenta l groups. 
In the definitive experimental protocol, groups of 6-10 mice were 
kept in one of the specially outfitted cages in the animal research 
facility and t he animals were fed standard lab chow and water as 
desired. Two groups of animals received daily (Monday through Friday) 
i.p. injections of eit her nalidixic ac id suspension, 150 mg/kg (group I) 
or saline (group II) , with 12 h daily exposure to UV radiation for periods 
of 6 weeks. An additional 2 groups of animals received daily i.p. 
intraperitoneal injections of either nalidixic acid, 150 mg/kg (group 
III) or saline (group IV) withour exposure to UV energy. At the end of 
6 weeks, UV radiat ion and nalidixic ac id administration were discon-
tinued for 1 week, after which t ime the animals were transferred to 
metabolic cages and pooled 24-h urine specimens were collected from 
each of the 4 groups for assays for quantitative uro- and coproporphyrin 
levels (Bio-Science Laboratories, Westmont, Illinois). Two weeks after 
UV irradiatio n was discontinued (at the beginning of the 9th week) the 
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IRRADIANCE OF TWO F15-T8 BLACK LIGHT BULBS 
AT A DISTANCE OF 17.5 em 
First set ••••• 
Second set . .... 
300 320 340 
WAVELENGTH (nm) 
360 380 400 
FI G 1. Irrad iance of la mps used in experiments, measured at the 
approximate working distance. 
a nimals aga in received daily na lidixic ac id or saline injections (Monday 
t hrough F riday) and 12-h da ily exposure to UV radiation for another 4 
weeks. At t he end of the 12th week, 4-mm punch biopsies were taken 
from t he plucked exposed a reas of t he back, fi xed in 4% buffe red 
glu ta ra ldehyde, and a port ion of each biopsy was processed rout inely 
fo r light microscopy. The remaining port ion of each biopsy was post-
fixed in 2% buffered osm ium tetroxide and processed for electron 
microscopy. 
RESULTS 
E xposure of t he plucked skin of t he bac k and of t he ears to 
UV radiation in group I animals produced marked erythema 
and scaling by t he end of t he 1st week, followed by erosions, 
crusting, and , ul t imately, some superficial ulcerations by t he 
end of t he 3rd week. In t he exposed skin of t he group II animals 
t he onset of erythema was delayed compared to group I animals, 
beginning by 10- 12 days, and erosions, crusting, or ulcerations 
we re uncommon, minor , and usually of short duration. Clinical 
th ickening of t he exposed skin was marked by the end of t he 
3rd week in group II animals. Frank bullae were not observed 
in group I or group II animals. Hair did not regrow in t he group 
I animals. In t he group II animals, hair regrowt h was slight ly 
delayed but was noted by t he 3rd week. Hair regrowt h in group 
III and IV animals proceeded at t he normal rate. Because of 
t he dramatic nature of t he skin changes in t he UV -exposed 
a reas after the 1st week, group I, group II, and group III- group 
IV animals could easily be di ffe rent iated from each other by 
simple examination of t he skin. Nalidixic acid (group III) - and 
saline (group IV)-t reated animals not exposed to UV radiation 
showed no gross skin or hair changes over t he 12-week study 
period. Fig 2 illustrates t he striking differences in the clinical 
appearances of t he groups at 4 weeks after t he onset of t he 
experiment . 
NAL rDIXIC- INDUCED PHOTOSENSIT IVITY 211 
Histopathologically, at 12 weeks fo llowing onset of t he ex-
periment, t he most striking feature was t he presence of dermal-
epidermal separation (Fig 3) in t he skin of 6 of 8 nalidixic acid-
UV -exposed animals (group I) . In some specimens t here was 
crusting with or wi thout underlying spongiosis. Ultrastruc-
turally, t he sepa ration occurred in t he papillary dermis beneath 
t he basal lamina (Fig 4). Ofte n segments of collagen fibrils 
remained on t he epidermal side of t he separation. No notable 
reduplication of the basal lamina was fo und. One of 8 sali ne 
t reated- UV -exposed animals (group II) also showed derma l-
epidermal separation, but t his separation was slight and oc-
curred at a di ffe ren t ul t rastructural level, namely in t he lamina 
FIG 2. Representative animals at 4 weeks following onset of radia-
t ion. Group l animal on left shows an erosive dermatitis with foca l 
reepit he lia li zation; group II animal in the center shows part ia l ha ir 
regrowth on t he back and nearly healed mild, crusting dermatitis, 
changes more severe t han t hose seen in most group II animals. T he 
hair of the group Ill animal on right has regrown (as did hair in t he 
group IV a nimals).The ears show an erosive dermatit is in the group l 
a nimal, mild dermatit is in t he group Il animal, and a re norma l in the 
group Ill animal. 
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FIG 4. Electron micrograph of early subepidermal separation in 
biopsy from bac k of a group I animal. Separation occurred in the plane 
of a band of degenerative vacuoles (arrow) (X 15,000). 
T ABL E L H istologic Features 
Dermal-epidermal separation 
Epidermal proliferation and 
dysplasia 
Epidermal atrophy 
De rmal fi brosis 
Moderate inf1ammatory cell 
infil t rate 
Cystic dege neration of 
fo llicles 
Nalacli xic 
ac icl-treated-
UV-exposed 
(group I) 
6/8 
5/8 
2/8 
4/8 
5/8 
4/8 
Saline-lreated-
UV-exposed 
(group II ) 
1/8 
3/8 
2/8 
1/8 
5/8 
2/8 
Iucida. By li ght microscopy, epidermal cell proliferation and 
dysp las ia were seen in 8 animals in group I and in 3 of 8 mice 
in group II (Tab le I) . Epiderma l atrophy and a mixed lympho-
histiocytic in fil t rate in t he dermis occurred in 5 of 8 animals in 
group I and 5 of 8 animals in group IL Ma rked fibrotic changes 
were present in 4 of 8 group I animals in contrast to 1 of 8 
group II anima ls. Cystic degeneration of t he follicles was found 
in 4 of 8 group I a nimals and in 2 of 8 group II animals. 
Nalidixic acid (group Ill) - and saline (group IV) -treated ani-
mals not exposed to UV radi ation showed no microscopic 
abnormali t ies in the skin . 
Twenty- four-hour urine coproporphyrin and uroporphyrin 
dete rminations showed li ttle variabili ty among the 4 groups. 
The average coproporphyrin determination for animals in 
groups I- IV was 33, 43 , 35, and 33 11g/li ter respectively, while 
the average uroporphyrin determination was 13, 13, 8, and 7 
11g/liter for animals in groups I- IV respect ively. Fluorescence 
microscopy of frozen sections cut from multiple skin biopsies 
taken t hroughout the period of experimental study were nega-
t ive for coral-red flu orescence. 
DISCUSSION 
PCT -like bli stering erupt ions, or "pseudoporphyria cutanea 
ta rda" type drug- induced photosensit ivity reactions, are defined 
by t heir distinct clinical and pathologic features. They are 
probably ident ical in pathology to condi t ions described under 
t he designation "bullous dermatosis of hemodialysis" [10] or 
"bullous dermatosis of chronic renal fa ilure" (11] . The site of 
blister formation is subepidermal and, in our experience, shows 
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essen tia lly t he same ul t rastructura l pathology as blister fo r-
mation in P CT (unpublished observations). Since porphyrin 
involvement in t he pathogenic mecha nism in some individua ls 
affected by these drug-induced photo reactions has been ruled 
out , it is likely t hat t he prima ry photoreact ion of t he drug in 
t he skin results in attack on t he same or a similar substrate as 
t hat involved in P CT ; from t hat poin t on, t he pat homecha nism s 
of the drug- induced condi t ion a nd PCT may be the same. 
An animal model for this type of drug photosensitivity would 
facili tate studies aimed at identifying such a hypothetical sub-
strate and t he subsequent cha in of pathologic events. The 
mouse model we have developed may qualify, in t hat t h e 
animals developed subepiderma l sepa ration in t he same plan e 
as t hat found in human drug- induced pseudoporphyria a nd in 
porphyri a cutanea tarda. Detailed action spectrum experi-
ments, t hough of photobiologic interest, were not carried ou t 
in t his ini t ia l investigation , since a n experimen tal pat hology 
model was t he primary goal of t he study. (A pilot experimen t 
was done by irradiat ing animals t hrough window glass. The 
resul ts suggested that t he photoreaction is probably induced by 
UVB, a presumpt ion not inconsistent wi t h the fact that na li -
dixic acid has a major abso rpt ion peak at 325 nm) . The previ-
ously devised original model for experimental hexachloroben -
zene-induced PCT in t he rat showed similar clinical and ult ra-
structural findin gs in t he skin [1 2]. In t hat earlier study a nd in 
t he present investigation t he mild, nonspecific, more tra nsien t 
inflammatory skin changes seen in the UV-exposed cont rol 
animals probably resulted from t he UVB port ions of t he blac k-
light bulb irradiation (Fig 1). Our mouse model may have much 
greater applicability t han for t he P CT -like photoreaction. It is 
advantageous in that the animals are subjected to chronic UV 
radiation so t hat weaker photosensitizers may be detected . In 
addi t ion, photoallergic agents can be administered for sufficien t 
sensit izing periods. The use of a radiation source that includes 
UVB a nd UV A provides the initial sc reening detection and 
study of agents requiring either ra nge of UV energy for the 
induction of a photoreaction. Once a reaction has been ob-
served , detailed UV spectrum studies may t hen be determined 
as des ired. 
A number of models for photosensit ivi ty testing have been 
developed previously. Of spec ial interest are t he studies of I son 
and Blank [13] in mice; Sams and Epstein [14] and Sa ms (1 5] 
in gu inea pigs; Schorr and Monash [16], Maibach, Sams, and 
Epste in [17], Kligman and Breit [18], a nd Kaidbey a nd Klig-
man [19] in humans. Those studies employed various artificia l 
UV radia tion sources and/or natural sunlight, but were all of 
short- term duration (up to about 6 days). While those studies 
produced useful data, our model seems more suitable for studies 
of pseudoporphyria type photoreactions and, perhaps, cert ain 
other types of photoreactions which require much more pro-
longed exposure t imes to provocative agen ts and to UV energy. 
The authors are indebted to Ed De Fabo, PhD, of the National 
Cancer Institute, Frederick Cancer Research Facili ty, Frederick, Mary-
land, 21701, for his assistance in determining the irradiance of the 15-
watt fluorescent black-light bulbs used in this study. 
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